Journals / Göztepe Tıp Dergisi / 2013 / Cilt: 28 - Sayı: 2

Moyamoya disease and anesthesia: TIVA & VIMA

Moyamoya hastalığı ve anestezi: TİVA & VİMA

Pages
95–100
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The goal for anesthesia is to maintain thebalance between the oxygen supply and demand in the brain.The factors like hypocapnie, hypotension should be avoided toprevent cerebral ischemia and cerebral hemorogy.In this case report, we discussed anesthetic management of a15 mount female patient with MMD who presented for twotimes myosynangyosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Moyamoya disease (MMD) is a rare chronic cerebrovasculardisease seen both in children and adults.
📊
Key Findings & Data:The disease causesischemic stroke, intracranial hemorrhage, headache, seizures,and transient ischemia attach in children and adults.
💡
Conclusion & Impact:The goal for anesthesia is to maintain thebalance between the oxygen supply and demand in the brain.The factors like hypocapnie, hypotension should be avoided toprevent cerebral ischemia and cerebral hemorogy.In this case report, we discussed anesthetic management of a15 mount female patient with MMD who presented for twotimes myosynangyosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Moyamoya disease (MMD) is a rare chronic cerebrovasculardisease seen both in children and adults. The disease causesischemic stroke, intracranial hemorrhage, headache, seizures,and transient ischemia attach in children and adults. There isno evidence associating the use of a particular anesthesiatechnique or drug with better outcome after induction or maintenanceof anesthesia in MMD patients. A variety of techniquesand medications are used, each with advantages and disadvantages.Induction may be achieved with inhalation or intravenoustechniques. The goal for anesthesia is to maintain thebalance between the oxygen supply and demand in the brain.The factors like hypocapnie, hypotension should be avoided toprevent cerebral ischemia and cerebral hemorogy.In this case report, we discussed anesthetic management of a15 mount female patient with MMD who presented for twotimes myosynangyosis.

Özet

Moyamoya hastalığı (MMH), çocuk ve erişkinlerde ender görülen kronik seyirli serebrovasküler hastalıktır. MMH, iskemik inme, intrakraniyal kanama, baş ağrısı, konvulsiyon ve geçici iskemik ataklara neden olur. MMH için, anestezi indüksiyonu ve idamesinde daha iyi sonuç verecek özel bir anestezi tekniği veya ilaç ilişkisi bulunmamaktadır. Çeşitli teknik ve tedaviler avantaj ve dezavantajları ile birlikte uygulanır. İnhalasyon ajanı veya intravenöz ilaçlar ile indüksiyon sağlanabilir. Anestezi uygulaması sırasında amaç, beyindeki oksijen sunumu ve kullanımı arasında denge sağlamaktır. Serebral hemoraji ve iskemiyi önlemek için, hipokapni ve hipotansiyon gibi faktörlerden sakınılmalıdır.

🔖

Cite This Article

DURANSOY, Y., AĞDANLI, D., KELEŞ, G. T., CANAN, S., TOPÇU, İ. (2022). Moyamoya disease and anesthesia: TIVA & VIMA. Göztepe Tıp Dergisi, Cilt: 28 - Sayı: 2, 95–100. https://ajindex.com/articles/526076

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Dagcınar A, Özek MM, Pamir MN. Moyamoya hastalı- ğı. Türk Nörosirurji Dergisi 2000;10:176-85
  2. Bıkmaz K, Cosar M, Başocak K, et al. Moyamoya hastalığı olan yedi yaşındaki çocukta çoklu burr-hole ile serebral revaskülarizasyon. Türk Nöroşirürji Dergisi 2004;14:59-63
  3. Erkal H, Gaygusuz EA, Temizel F, ve ark. Moyamoya hastalığında anestezi: Olgu sunumu. J Kartal TR 2009;20:142-45
  4. Aydoğan MS, Yücel A, Özgül Ü, ve ark. Erişkin moyamoya hastasına anestetik yaklaşım: olgu sunumu. Gülhane Tıp Dergisi 2010;52:212-15
  5. Baykan N, Özgen S, Ustalar S, et al. Moyamoya disease and anesthesia. Pediatric Anesthesia 2005;15:1111-15. http://dx.doi.org/10.1111/j.1460-9592.2005.01576.x PMid:16324034 6. Kuroda S, Ishikawa T, Houkin K, Nanba R, et al. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005;36:2148-2153. http://dx.doi.org/10.1161/01.STR.0000182256.32489.99 PMid:16179571 7. Baaj A, Agazzi S, Sayed Z, et al. Surgical management of moyamoya disease: a review. Neurosurg Focus 2009;26:E7. http://dx.doi.org/10.3171/2009.01.FOCUS08293 PMid:19335133 8. Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. J Neurosurg 2009;111:927-935. http://dx.doi.org/10.3171/2009.4.JNS081649 PMid:19463046 9. Kansha M, Irita K, Takahashi S, et al. Anesthetic management of children with moyamoya disease. Clin Neurol Neurosurg 1997;99:110-13.
  6. Sato K, Shirane R, Kato M, et al. Effect ofinhalational anesthesia on cerebral circulation in moyamoya disease. J Neurosurg Anesthesiol 1999;11:25-30. http://dx.doi.org/10.1097/00008506-199901000-00005 PMid:9890382 11. Kikuta K, Takagi Y, Nozaki K, et al. Effects of intravenous anesthesia with propofol on regional cortical blood flow and intracranial pressure in surgery for moyamoya disease. Surgical Neurol 2007;68:421-424. http://dx.doi.org/10.1016/j.surneu.2006.11.064 PMid:17586011 12. Erden İA, Uzun Ş, Şahin A, ve ark. Moyamoya hastalı- ğında anestetik yaklaşım. Türk Anest Rean Derg 2007;35:358-62
  7. Matsushima Y, Aoyagi M, Suzuki R, et al. Perioperative complications of encephalo-duro-arterio-synangiosis: prevention and treatment. Surg Neurol 1991;36:343-53.
  8. Hallemeier C, Rich K, Grubb R, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006,37:1490-1496. http://dx.doi.org/10.1161/01.STR.00